Celgene (CELG) Announces Positive Results From Phase III SUNBEAM Trial Of Oral Ozanimod In Patients With Relapsing Multiple Sclerosis
5 Best U.S. Regions for Life Science Jobs
Bay Area Biotech Surrozen Launches With $33 Million and Could Double Its Headcount by Next Year
New SoCal Biotech Jecure Therapeutics Makes Debut and Will Take on NASH
4 Biopharma Stocks a Billionaire Investor Just Bought
How Much Money Embattled Theranos Has Left in the Bank
Woman to Watch: Meet the Woman Who is Helming Boston's Cocoon Biotech
SAGE Therapeutics (SAGE) Boss Gets Overenthusiastic About Drug, Walks Back Discussion of M&A Activity
3 Biotechs With the Biggest and Most Promising Pipelines
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial
After Merck & Co. (MRK) & Eli Lilly (LLY) Alzheimer’s Failures, A Look at 7 Companies Still on the Hunt
Here Are 5 Tricky Job Interview Questions You Might Get at Genentech (RHHBY), Regeneron (REGN), and Stratos
Swiss Biotech Santhera (SANN.SW) Opens Up 20 Employee Shop in Massachusetts, Has Plans to Grow
AMAG (AMAG) to Hire 150 New Sales Reps to Support New Drug Intrarosa
Duke University Medical Center Release: Discovery Of A Gene Function Sheds Light On New Treatment Strategies For Amyotrophic Lateral Sclerosis (ALS)
Takeda (TKPYY) Completes Acquisition Of Ariad (ARIA)
AcelRx (ACRX) Appoints Vincent J. Angotti Chief Executive Officer
With Ex-Juno (JUNO) Employees on Its Roster, Seattle's Silverback Therapeutics Files $10 Million Out of $60 Million Goal
See All News >